By
Jennifer Braun Published January 3, 2025 Download
Print
Text size
Bio-aesthetics company Carmell Corporation announced on Thursday its acquisition of Elevai Skincare Inc., a subsidiary of PMGC Holdings Inc.
As part of the agreement, Carmell will acquire Elevai’s product portfolio, which generated approximately $2.5 million in trailing twelve-month revenue, along with its commercial and product development teams. The deal also includes finished and in-process inventory valued at $1.0 million and accounts receivable of $0.03 million.
Under the definitive purchase agreement, Carmell will issue approximately $1.1 million in common stock at closing and pay $57,000 in cash contingent on the sale of existing inventory.
2025-01-10 09:00
2025-01-10 08:39
2025-01-10 08:33
2025-01-10 06:59
2025-01-10 06:57
2025-01-10 06:41